A.R.T. Advisors’s Therapix Biosciences Ltd. TRPX Stock Holding History

A.R.T. Advisors’s Portfolio TRPX Stock Details TRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,504	Closed	-$15K	–	1254
2019 Q4	$15K	Buy	+13,504	New	+$24.9K	﹤0.01%	1287

Other funds holding TRPX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

A.R.T. Advisors's TRPX Position: Q1 2020 in Review

A.R.T. Advisors sold out of Therapix Biosciences Ltd. (TRPX) in Q1 2020, closing a stake of 13,504 shares — an estimated $15K sold.

A.R.T. Advisors first reported a position in TRPX in Q4 2019 and held it in 1 quarter. The position peaked at $15K in Q4 2019. 4 funds tracked by Wall St. Rank hold TRPX as of Q1 2020.

A.R.T. Advisors reported no remaining Therapix Biosciences Ltd. position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 13,504 Therapix Biosciences Ltd. shares in Q1 2020, an estimated $15K.
A.R.T. Advisors first reported a position in Therapix Biosciences Ltd. in Q4 2019 and held it in 1 quarter.
A.R.T. Advisors's Therapix Biosciences Ltd. position peaked at $15K in Q4 2019.
4 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.